The mission of the American Society of Clinical Psychopharmacology is to advance the science, practice, and education of clinical psychopharmacology, and to improve the health and well-being of our patients.
OUR VISION STATEMENT
The ASCP will be the leading source of innovation in research, education and practice for psychopharmacology and other treatment modalities to improve the lives of those with psychiatric disorders.
- Enhance the development of cutting-edge research in the field of clinical psychopharmacology and related fields by providing investigators and clinicians the opportunity to engage in discussion, education, and dissemination of research findings and new methodologies.
- Enhance ASCP’s role as the preeminent leader in innovative education in clinical psychopharmacology and related fields to foster the development of best practices, new treatments, curricula, and training for all career levels.
- Increase the leadership, membership, and participation of all underrepresented groups in the Society by cultivating inclusion to ensure that all members, meeting attendees, and collaborators feel welcomed, empowered, and valued.
- Develop initiatives, partnerships, and collaborations that bring together leading experts from diverse settings - including academic, industry, clinical, and government - to advance the field of psychopharmacology.
OUR DIVERSITY STATEMENT
The organization has a commitment to actively promote and welcome diversity and inclusion within the society and within our field. Diversity includes but is not limited to race, ethnicity, religion, disability, age, sex, gender identity, sexual orientation, intellectual perspectives and points of view.
OUR STATEMENT ON INCLUSIVITY“Of all the forms of inequality, injustice in health is the most shocking and inhumane.” - The Reverend Dr. Martin Luther King, Jr.
As we have witnessed in horror and profound sadness the most recent abhorrent examples of police brutality and racism, our thoughts of sympathy and fellowship go to the families and loved ones of those who have died and, by extension, to the broader African American community and all individuals who have lived inequalities and other forms of injustice. These events are the most recent and graphic illustration of the tragic consequences of racism and social disparities we sadly witness routinely as health professionals.
We at the American Society of Clinical Psychopharmacology emphatically reject racism and other forms of injustice. We value and pursue a climate of equity and inclusion that is embraced and championed by all as affirmed in our Inclusivity Statement: “ASCP has a commitment to actively promote and welcome diversity and inclusion within the society and within our field. Diversity includes but is not limited to race, ethnicity, religion, disability, age, sex, gender identity, sexual orientation, intellectual perspectives and points of view. ASCP encourages and promotes membership and contributions from individuals who identify as members of minoritized communities.”
ASCP continues to aspire to become an exemplary leader in creating an inclusive and welcoming environment wherein everyone can learn, develop, innovate and flourish. Consistent with this commitment, the ASCP have adopted anti-racism practices and specific initiatives to promote a more diverse membership, pledge to continue to monitor our progress on an ongoing basis, endeavor to host a more inclusive Annual Meeting experience including curricular content and diversity of speakers, promoting, among others, racial/ethnic and gender equality in leadership and opportunity for all groups.